• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Surges 350 Points; Fed Holds Rates Steady

    3/20/24 3:22:15 PM ET
    $AQST
    $ETAO
    $LFCR
    $SIG
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Blank Checks
    Finance
    Get the next $AQST alert in real time by email

    U.S. stocks traded higher toward the end of trading, after the Federal Reserve left rates unchanged.

    The Dow traded up 0.91% to 39,467.76 while the NASDAQ rose 1.08% to 16,341.42. The S&P 500 also rose, gaining, 0.78% to 5,218.70.

    Check This Out: Exxon Mobil, Palantir Technologies And 2 Other Stocks Insiders Are Selling

     

    Leading and Lagging Sectors

    Industrials shares rose by 0.4% on Wednesday.

    In trading on Wednesday, health care shares fell by 0.7%.

     

    Top Headline

    The Federal Reserve kept interest rates unchanged Wednesday between 5.25% and 5.5% at its March meeting, as widely expected by investors, confirming intentions to lower the cost of money in the coming months.

     

    Equities Trading UP

    ETAO International Co., Ltd. (NASDAQ:ETAO) shares shot up 87% to $0.2670. The company announced a reverse stock split.

    Shares of XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) got a boost, surging 90% to $1.96 after the company announced plans to acquire The Social Proxy.

    TruGolf Holdings, Inc. (NASDAQ:TRUG) shares were also up, gaining 48% to $1.70 after the company announced a newly expanded AI technology licensing agreement with mlSpatial.

     

    Equities Trading DOWN

    Lifecore Biomedical, Inc. (NASDAQ:LFCR) shares dropped 32% to $4.9050 after the company announced it concluded its strategic evaluation process, announced management succession and board changes.

    Shares of Aquestive Therapeutics, Inc. (NASDAQ:AQST) were down 16% to $4.47. Aquestive Therapeutics priced its $75 million underwritten public offering of 16,666,667 common shares at $4.50 per share.

    Signet Jewelers Limited (NYSE:SIG) was down, falling 10% to $92.17 after the company reported worse-than-expected fourth-quarter sales and issued weak FY25 guidance.

    Also Check This Out: Top 5 Industrials Stocks That Are Preparing To Pump In Q1

     

    Commodities

    In commodity news, oil traded down 2% to $81.84 while gold traded up 1.3% at $2,187.90.

    Silver traded up 2.6% to $25.80 on Wednesday, while copper rose 0.4% to $4.0890.

     

    Euro zone

    European shares closed mixed today. The eurozone’s STOXX 600 fell 0.05%, London’s FTSE 100 slipped 0.01% while Spain’s IBEX 35 Index rose 0.48% The German DAX rose 0.15% French CAC 40 fell 0.48% while Italy’s FTSE MIB Index gained 0.09%.

    Industrial production in Italy declined by 1.2% month-over-month in January compared to a revised 1.2% surge in December. Producer prices in Germany fell by 4.1% year-over-year in February.

    UK’s producer prices increased by 0.4% year-over-year in February, while inflation rate eased to 3.4% year-over-year in February.

     

    Asia Pacific Markets

    Asian markets closed higher on Wednesday, with Hong Kong’s Hang Seng Index rising 0.08%, China’s Shanghai Composite Index gaining 0.55% and India’s S&P BSE Sensex gaining 0.1%.

    The People's Bank of China held benchmark lending rates at the recent fixing.

     

    Economics

    U.S. mortgage applications declined by 1.6% on the week ending March 15.

    Crude oil inventories in the U.S. declined by 1.952 million barrels in the week ended March 15, versus market estimates of a 0.013 million gain.

    The Fed kept interest rates unchanged between 5.25% and 5.5% at its March meeting.

    Now Read This: Netflix To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday

    Get the next $AQST alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AQST
    $ETAO
    $LFCR
    $SIG

    CompanyDatePrice TargetRatingAnalyst
    Signet Jewelers Limited
    $SIG
    12/11/2025$96.00Neutral
    Goldman
    Signet Jewelers Limited
    $SIG
    12/3/2025$92.00 → $96.00Market Perform
    Telsey Advisory Group
    Signet Jewelers Limited
    $SIG
    11/11/2025$150.00Overweight
    Stephens
    Lifecore Biomedical Inc.
    $LFCR
    9/4/2025Sector Weight
    KeyBanc Capital Markets
    Signet Jewelers Limited
    $SIG
    7/25/2025$80.00 → $92.00Market Perform
    Telsey Advisory Group
    Signet Jewelers Limited
    $SIG
    6/16/2025$102.00Buy
    Jefferies
    Signet Jewelers Limited
    $SIG
    6/4/2025$62.00 → $80.00Market Perform
    Telsey Advisory Group
    Aquestive Therapeutics Inc.
    $AQST
    6/2/2025$7.00Outperform
    Oppenheimer
    More analyst ratings

    $AQST
    $ETAO
    $LFCR
    $SIG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Signet Jewelers with a new price target

    Goldman initiated coverage of Signet Jewelers with a rating of Neutral and set a new price target of $96.00

    12/11/25 9:14:03 AM ET
    $SIG
    Consumer Specialties
    Consumer Discretionary

    Telsey Advisory Group reiterated coverage on Signet Jewelers with a new price target

    Telsey Advisory Group reiterated coverage of Signet Jewelers with a rating of Market Perform and set a new price target of $96.00 from $92.00 previously

    12/3/25 7:52:34 AM ET
    $SIG
    Consumer Specialties
    Consumer Discretionary

    Stephens initiated coverage on Signet Jewelers with a new price target

    Stephens initiated coverage of Signet Jewelers with a rating of Overweight and set a new price target of $150.00

    11/11/25 8:07:17 AM ET
    $SIG
    Consumer Specialties
    Consumer Discretionary

    $AQST
    $ETAO
    $LFCR
    $SIG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Sagi Raghunandan R was granted 5,405 shares (SEC Form 4)

    4 - SIGNET JEWELERS LTD (0000832988) (Issuer)

    1/14/26 6:02:37 PM ET
    $SIG
    Consumer Specialties
    Consumer Discretionary

    SEC Form 3 filed by new insider Sagi Raghunandan R

    3 - SIGNET JEWELERS LTD (0000832988) (Issuer)

    1/14/26 6:01:21 PM ET
    $SIG
    Consumer Specialties
    Consumer Discretionary

    Officer Ptak Stash gifted 1,160 shares, decreasing direct ownership by 5% to 22,066 units (SEC Form 4)

    4 - SIGNET JEWELERS LTD (0000832988) (Issuer)

    12/5/25 4:01:27 PM ET
    $SIG
    Consumer Specialties
    Consumer Discretionary

    $AQST
    $ETAO
    $LFCR
    $SIG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mccluskey Helen bought $100,057 worth of shares (1,700 units at $58.86), increasing direct ownership by 6% to 31,916 units (SEC Form 4)

    4 - SIGNET JEWELERS LTD (0000832988) (Issuer)

    4/28/25 7:41:57 PM ET
    $SIG
    Consumer Specialties
    Consumer Discretionary

    Chief Executive Officer Symancyk James Kevin bought $861,735 worth of shares (15,000 units at $57.45), increasing direct ownership by 42% to 50,710 units (SEC Form 4)

    4 - SIGNET JEWELERS LTD (0000832988) (Issuer)

    3/31/25 4:58:42 PM ET
    $SIG
    Consumer Specialties
    Consumer Discretionary

    Chief Executive Officer Josephs Paul bought $97,580 worth of shares (17,000 units at $5.74), increasing direct ownership by 3% to 559,717 units (SEC Form 4)

    4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)

    1/8/25 4:10:19 PM ET
    $LFCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AQST
    $ETAO
    $LFCR
    $SIG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TruGolf Stock Repurchase Activity

    SALT LAKE CITY, UT, Feb. 10, 2026 (GLOBE NEWSWIRE) -- TruGolf Holdings Inc. (NASDAQ:TRUG) today announced an update on its stock repurchase activity. The Company has repurchased 423,402 shares of its Class A common stock under its previously announced $2 million stock repurchase program. The shares were purchased at an average price of $0.7552 per share, including all fees and commissions. Approximately $1.67 million remains available under the repurchase program. "Following our strong showing at January's PGA show, the Company remains optimistic about its future prospects and the potential of its revamped product lineup." said Chris Jones, Chief Executive Officer of TruGolf. TruGolf exp

    2/10/26 8:00:00 AM ET
    $TRUG
    Recreational Games/Products/Toys
    Consumer Discretionary

    TruGolf Builds on PGA Show Momentum, Announces Major Q1 2026 Launch with D3 Sports Tech

    SALT LAKE CITY, UT, Feb. 04, 2026 (GLOBE NEWSWIRE) -- TruGolf Holdings Inc. (NASDAQ:TRUG), Fresh off a standout showing at the January PGA Golf Show, TruGolf is accelerating into its next chapter of innovation, announcing a major upcoming platform launch in Q1 2026 in collaboration with D3 Sports Tech (D3ST). At the PGA Show, TruGolf captured industry-wide attention with the debut of the TruGolf RANGE, a first-of-its-kind experience capable of supporting seven simultaneous players hitting indoors at once. The activation quickly became one of the most talked-about experiences on the show floor, sparking widespread excitement across the golf community. Now, TruGolf is channeling that momen

    2/4/26 8:30:00 AM ET
    $TRUG
    Recreational Games/Products/Toys
    Consumer Discretionary

    Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™

    Deficiencies limited to packaging and administrationCompany believes it can rapidly resolve deficiencies and expects to resubmit as early as Q3 2026Remains well-capitalized and anticipates ending 2026 with significant cashReiterates plans to submit in Canada and EU by the end of 2026Company to host investor call on February 2, 2026, at 8:00am ET WARREN, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that it received a Complete Response Letter (CRL) from the U

    2/2/26 7:00:00 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AQST
    $ETAO
    $LFCR
    $SIG
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for LIBERVANT issued to AQUESTIVE THERAPEUTICS INC

    Submission status for AQUESTIVE THERAPEUTICS INC's drug LIBERVANT (ORIG-1) with active ingredient DIAZEPAM has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218623, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    4/29/24 7:48:13 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AQST
    $ETAO
    $LFCR
    $SIG
    SEC Filings

    View All

    TruGolf Holdings Inc. filed SEC Form 8-K: Other Events

    8-K - TruGolf Holdings, Inc. (0001857086) (Filer)

    2/10/26 8:46:40 AM ET
    $TRUG
    Recreational Games/Products/Toys
    Consumer Discretionary

    SEC Form DEFA14A filed by TruGolf Holdings Inc.

    DEFA14A - TruGolf Holdings, Inc. (0001857086) (Filer)

    2/4/26 4:39:52 PM ET
    $TRUG
    Recreational Games/Products/Toys
    Consumer Discretionary

    TruGolf Holdings Inc. filed SEC Form 8-K: Other Events

    8-K - TruGolf Holdings, Inc. (0001857086) (Filer)

    2/2/26 8:30:44 AM ET
    $TRUG
    Recreational Games/Products/Toys
    Consumer Discretionary

    $AQST
    $ETAO
    $LFCR
    $SIG
    Leadership Updates

    Live Leadership Updates

    View All

    Shareholders Elect Four Independent Directors to the Six Flags Board

    Six Flags Entertainment Corporation (NYSE:FUN), the largest regional amusement park operator in North America, announced today that its shareholders elected Sandra (Sandy) Cochran, Michael Colglazier, Felipe Dutra, and Steven Hoffman to the Board of Directors of Six Flags Entertainment Corporation for 3-year terms expiring in 2028. Shareholders also confirmed the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm, approved an advisory vote on the compensation of the Company's named executive officers, and confirmed a 1-year frequency for shareholder advisory votes on executive compensation. "I want to welcome Sandy, Michael, Felipe and St

    6/25/25 5:00:00 PM ET
    $BUD
    $CBRL
    $DG
    Beverages (Production/Distribution)
    Consumer Staples
    Restaurants
    Consumer Discretionary

    IFF Appoints Virginia "Gina" Drosos to Board of Directors

    IFF (NYSE:IFF)—a global leader in flavors, fragrances, food ingredients, health and biosciences—today announced the appointment of Gina Drosos to its board of directors, effective June 16. Drosos brings more than 30 years of executive leadership experience across the retail, consumer goods, beauty and health care industries. "We are very pleased to welcome Gina to the IFF board," said Kevin O'Byrne, chair of the board. "Gina brings extensive relevant experience, deep consumer insights and a proven ability to drive innovation and lead with purpose, which aligns with our long-term strategy to deliver sustainable growth and value creation for all stakeholders." Drosos most recently served

    6/9/25 5:46:00 PM ET
    $IFF
    $PG
    $SIG
    Major Chemicals
    Industrials
    Package Goods/Cosmetics
    Consumer Discretionary

    Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer

    Mr. DaFonseca Possesses Nearly 30 Years of Broad Drug Development Experience, including More than 15 Years Leading High Performing CDMO Sales Organizations Will Leverage Deep Pharma Services Expertise as Leader of Lifecore's Sales Organization Focused on Executing Three-Pronged Growth Strategy CHASKA, Minn., May 27, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:LFCR) ("Lifecore"), a fully integrated contract development and manufacturing organization ("CDMO"), today announced that it has appointed Mark DaFonseca as chief commercial officer.   A seasoned CDMO and pharmaceutical services executive, Mr. DaFonseca has nearly 30 years of pharmaceutical industry experience spannin

    5/27/25 7:00:00 AM ET
    $LFCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AQST
    $ETAO
    $LFCR
    $SIG
    Financials

    Live finance-specific insights

    View All

    Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™

    Deficiencies limited to packaging and administrationCompany believes it can rapidly resolve deficiencies and expects to resubmit as early as Q3 2026Remains well-capitalized and anticipates ending 2026 with significant cashReiterates plans to submit in Canada and EU by the end of 2026Company to host investor call on February 2, 2026, at 8:00am ET WARREN, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that it received a Complete Response Letter (CRL) from the U

    2/2/26 7:00:00 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Signet Jewelers Reports Third Quarter Fiscal 2026 Results

    Q3 Same Store Sales1 Growth of 3% Signet Jewelers Limited ("Signet" or the "Company") (NYSE:SIG) today announced its results for the 13 weeks ended November 1, 2025 ("third quarter Fiscal 2026"). "Signet's Grow Brand Love strategy delivered 3% same store sales growth led by Kay, Zales, and Jared which reflects our continued focus on our largest brands. Our balanced diamond assortment strategy, alongside ongoing stabilization in diamond retail prices, is driving growth and expanded average retails in both Bridal and Fashion," said J.K. Symancyk, Chief Executive Officer. "Looking forward, we believe we are well positioned for the holiday season with a focused assortment in key categories an

    12/2/25 6:50:00 AM ET
    $SIG
    Consumer Specialties
    Consumer Discretionary

    TruGolf Reports Third Quarter 2025 Results: Strong Margins, Strengthened Balance Sheet, and Expanding Contract Revenue Supports Long-Term Growth Strategy

    Salt Lake City, Utah, Nov. 17, 2025 (GLOBE NEWSWIRE) -- TruGolf Holdings, Inc. (NASDAQ:TRUG), a leading provider of golf simulator software and hardware, today reported its third quarter 2025 results. Third Quarter 2025 vs. Third Quarter 2024: Financial Highlights Cash: $11.4 million unrestricted; $13.5 million including restricted cash, up 30% from December 31, 2024.Total liabilities decreased to $16.7 million from $21.8 million at year-end, following the exchange of certain convertible notes into equity and settlement of merger-related obligations.Gross Margin: 69%, up sequentially from second quarter 2025.Remaining contract performance obligations of approximately $6.2 million. The C

    11/17/25 8:30:00 AM ET
    $TRUG
    Recreational Games/Products/Toys
    Consumer Discretionary

    $AQST
    $ETAO
    $LFCR
    $SIG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Aquestive Therapeutics Inc.

    SC 13G/A - Aquestive Therapeutics, Inc. (0001398733) (Subject)

    11/14/24 3:47:19 PM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by TruGolf Holdings Inc.

    SC 13G - TruGolf Holdings, Inc. (0001857086) (Subject)

    9/27/24 5:13:17 PM ET
    $TRUG
    Recreational Games/Products/Toys
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Lifecore Biomedical Inc.

    SC 13D/A - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Subject)

    7/5/24 2:17:24 PM ET
    $LFCR
    Biotechnology: Pharmaceutical Preparations
    Health Care